A 2-Week Ketogenic Diet in Combination With Letrozole to Modulate PI3K Signaling in ER+ Breast Cancer
Clinical trial NCT03962647 · COMPLETED
Trial details
- NCT number
- NCT03962647
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-08
- Primary completion
- 2024-03-07
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.